Zai Lab Ltd (ZLAB) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $19.69
• Market Cap: $2.17B
• EPS: $-1.90
• 52-Week High: $44.34
• 52-Week Low: $15.96

Market Sentiment

Zai Lab Ltd currently has a Neutral sentiment score of 0.05.

About Zai Lab Ltd

Zai Lab Limited (ZLAB) is a prominent biopharmaceutical company headquartered in Shanghai, China, dedicated to the discovery, development, and commercialization of innovative therapies targeting cancer, autoimmune disorders, and infectious diseases. With a robust pipeline of novel drug candidates and a strategic focus on fostering global partnerships, Zai Lab is well-equipped to meet the significant unmet medical needs in China and internationally. The company is positioned to leverage the ra...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Zai Lab Ltd and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ZLAB pay dividends?

Zai Lab Ltd (ZLAB) does not currently pay a regular dividend.

What is ZLAB's market cap?

Zai Lab Ltd (ZLAB) has a market capitalization of $2.17B with a current stock price of $19.69.